Cedar Highlights AI Billing Assistant as OpenAI Expands Into Healthcare
AI adoption in healthcare is spreading across drug discovery, clinical trials, and patient billing workflows.
Cedar, the patient financial engagement company, appeared in an NBC segment alongside OpenAI and QuantHealth as artificial intelligence deployment expands across different parts of the healthcare system.
OpenAI said it is developing a new AI model focused on life sciences and drug discovery. The company is targeting pharmaceutical research workflows, where timelines and costs remain high.
QuantHealth is applying AI to clinical trials. The company uses simulation models to identify which drugs are more likely to succeed, with the aim of reducing development timelines. A company representative said AI could cut the time required for drug approval by half within 10 years.
Cedar’s focus is narrower. It is applying AI to the patient financial experience, specifically billing, payments, and affordability, alongside other healthcare AI companies
AI moves into healthcare’s financial layer
Healthcare billing remains one of the most fragmented parts of the system. Patients often receive multiple bills from providers and insurers, with limited clarity on what they owe or how to pay. This creates delays in payment and increases administrative workload for providers.
Cedar builds software that consolidates billing and payment workflows into a single interface. The company has positioned financial experience as part of care delivery, tied to both patient outcomes and provider revenue.
In the NBC segment, Cedar President Seth Cohen described the company’s use of agentic AI to manage patient interactions.
“Health care is a uniquely exciting space for AI adoption and at Cedar, a company working on health care billing, they're using agentic AI to try to simplify the process for patients,” Cohen said.
Cedar’s AI assistant, referred to as Cora, is designed to handle billing conversations directly with patients. “An agentic AI product that will talk to you. Her name is Cora, and she will walk you through what you owe and how you can pay it, and she's available to talk to you 24 hours a day, seven days a week,” Cohen said.
These systems fall under a broader class of agentic AI applications designed to handle customer-facing workflows.
The system is intended to replace or reduce call center interactions tied to billing questions. These interactions account for a significant share of administrative costs for healthcare providers.
Parallel AI development across healthcare functions
The segment places Cedar within a broader pattern of AI adoption that is developing across separate parts of the healthcare system. Each application targets a different constraint.
OpenAI’s work focuses on research and drug discovery, where AI is used to analyze biological data and accelerate early-stage development. QuantHealth is focused on clinical validation, using AI to simulate trial outcomes and reduce uncertainty before drugs reach patients.
Cedar operates in the financial layer, where the primary constraint is administrative complexity rather than scientific uncertainty. The company’s tools are designed to improve how patients understand bills, identify payment options, and complete transactions.
These systems do not overlap directly. They operate across different stages of the healthcare process, from drug creation to treatment access and payment.
The expansion of AI into these areas reflects the structure of the healthcare system itself. Clinical innovation, trial efficiency, and financial operations are managed separately, with different data systems and workflows.
The NBC segment shows that AI deployment is following those boundaries. Companies are building systems tied to specific operational problems rather than applying a single model across the entire system.
Cedar’s inclusion in the segment reflects growing attention on the financial side of healthcare, where billing and affordability continue to affect both patient access and provider performance.